Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial.

Rania HammamiOmar MasmoudiJihen JdidiMouna TurkiRim CharfiImtinene Ben MradAmine BahloulTarek EllouzeRania GargouriSamir KammounSelma CharfeddineFatma AyediLeila Abid

Published in: PloS one (2023)

Our study did not find a benefit of systematic atorvastatin reloading in patients on chronic atorvastatin therapy in preventing CIN. However, it suggested that this strategy could reduce the risk of CyC-based CIN in diabetic type 2 patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
stem cells
chronic kidney disease
coronary artery disease
magnetic resonance
type diabetes
cardiovascular disease
prognostic factors
peritoneal dialysis
mesenchymal stem cells
contrast enhanced